1. Home
  2. TRUP vs ADPT Comparison

TRUP vs ADPT Comparison

Compare TRUP & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUP
  • ADPT
  • Stock Information
  • Founded
  • TRUP 2000
  • ADPT 2009
  • Country
  • TRUP United States
  • ADPT United States
  • Employees
  • TRUP N/A
  • ADPT N/A
  • Industry
  • TRUP Medical Specialities
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TRUP Health Care
  • ADPT Health Care
  • Exchange
  • TRUP Nasdaq
  • ADPT Nasdaq
  • Market Cap
  • TRUP 2.1B
  • ADPT 1.8B
  • IPO Year
  • TRUP 2014
  • ADPT 2019
  • Fundamental
  • Price
  • TRUP $49.38
  • ADPT $11.82
  • Analyst Decision
  • TRUP Buy
  • ADPT Strong Buy
  • Analyst Count
  • TRUP 6
  • ADPT 7
  • Target Price
  • TRUP $53.80
  • ADPT $10.57
  • AVG Volume (30 Days)
  • TRUP 565.7K
  • ADPT 2.4M
  • Earning Date
  • TRUP 08-07-2025
  • ADPT 07-31-2025
  • Dividend Yield
  • TRUP N/A
  • ADPT N/A
  • EPS Growth
  • TRUP N/A
  • ADPT N/A
  • EPS
  • TRUP N/A
  • ADPT N/A
  • Revenue
  • TRUP $1,321,538,000.00
  • ADPT $189,527,000.00
  • Revenue This Year
  • TRUP $11.30
  • ADPT $24.46
  • Revenue Next Year
  • TRUP $6.01
  • ADPT $20.25
  • P/E Ratio
  • TRUP N/A
  • ADPT N/A
  • Revenue Growth
  • TRUP 14.08
  • ADPT 8.61
  • 52 Week Low
  • TRUP $28.73
  • ADPT $3.51
  • 52 Week High
  • TRUP $57.90
  • ADPT $12.43
  • Technical
  • Relative Strength Index (RSI)
  • TRUP 41.85
  • ADPT 63.35
  • Support Level
  • TRUP $51.07
  • ADPT $11.41
  • Resistance Level
  • TRUP $53.61
  • ADPT $12.36
  • Average True Range (ATR)
  • TRUP 2.14
  • ADPT 0.59
  • MACD
  • TRUP -0.92
  • ADPT -0.01
  • Stochastic Oscillator
  • TRUP 0.98
  • ADPT 72.65

About TRUP Trupanion Inc.

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

Share on Social Networks: